INCB 3284 is primarily investigated for its potential therapeutic applications in medical research, particularly in the field of oncology. It is studied for its role in modulating specific biological pathways that are implicated in cancer progression. Researchers are exploring its efficacy in targeting and inhibiting certain enzymes or receptors that contribute to tumor growth and metastasis. Additionally, INCB 3284 is being examined for its possible use in combination therapies to enhance the effectiveness of existing cancer treatments. Its application extends to preclinical studies aimed at understanding its mechanism of action and safety profile, which could pave the way for future clinical trials in cancer patients.